During the past decade, Opelousas General Hospital Wound Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Opelousas General Hospital Wound Center" #1 collaborator was "Continuum Clinical Inc." with 1 trials as a collaborator, "Organogenesis" with 1 trials as a collaborator and "SerenaGroup Research Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Opelousas General Hospital Wound Center" are "COVID-19" (1 trials), "Chronic Vascular Ulcer" (1 trials), "Diabetic Foot Ulcer" (1 trials), "Diabetic Ulcer" (1 trials) and "Draining Wounds" (1 trials). Many other conditions were trialed in "Opelousas General Hospital Wound Center" in a lesser frequency.

Most popular intervention types in "Opelousas General Hospital Wound Center" are "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "3C Patch" (1 trials), "Affinity" (1 trials), "NuShield" (1 trials), "PuraPly™ Antimicrobial Wound Matrix" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Opelousas General Hospital Wound Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Opelousas General Hospital Wound Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Opelousas General Hospital Wound Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Opelousas General Hospital Wound Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".